Cargando…

257. Staphylococcus aureus Bacteremia: Does Intravenous Drug Use Impact Quality of Care and Clinical Outcomes?

BACKGROUND: Individuals with intravenous drug use (IDU) have higher risk for Staphylococcus aureus bacteremia (SAB) and increased management complexity. The goal of this study was to compare differences in SAB characteristics, adherence to standard of care metrics, and clinical outcomes in those wit...

Descripción completa

Detalles Bibliográficos
Autores principales:	McClellan, Kristen, Hilsendager, Cami, Luke, Strnad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Poster Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7778082/ http://dx.doi.org/10.1093/ofid/ofaa439.301

Ejemplares similares

209. What’s So Complicated About Complicated Staphylococcus aureus Bacteremia: Does Day 5 Matter?
por: Hilsendager, Cami, et al.
Publicado: (2019)

Treatment of Staphylococcus aureus Bacteremia in Children: Is Intravenous Therapy Always Needed?
por: Dona, Daniele, et al.
Publicado: (2017)

117. Adjunctive Daptomycin in the Treatment of staphylococcus Aureus Bacteremia
por: Cheng, Matthew P, et al.
Publicado: (2020)

269. Clinical Characteristics and Outcomes of Persistent Staphylococcus aureus Bacteremia
por: Yang, Eunmi, et al.
Publicado: (2020)

1268. Dalbavancin for the Treatment of Infections due to Staphylococcus aureus
por: Streifel, Amber C, et al.
Publicado: (2020)

850. External Validation of the Methicillin-Resistant Staphylococcus aureus Bacteremia Score
por: Boyle, Ellen, et al.
Publicado: (2020)

263. An Evaluation of Quality Indicators for the Management of Staphylococcus aureus Bacteremia: A Nested Case-Control Study
por: Simms, Andrew, et al.
Publicado: (2020)

291. Impact of Surveillance and Offered Infectious Diseases Consults for Staphylococcus aureus Bacteremia on Quality of Care Indicators
por: Jhaveri, Khushali, et al.
Publicado: (2020)

851. Compliance with Guidelines for Management of Staphylococcus aureus Bacteremia and its Effect on Mortality
por: Travez, Robert D, et al.
Publicado: (2020)

266. Ceftriaxone Versus Cefazolin for the Treatment of Methicillin-Susceptible Staphylococcus aureus Bacteremia
por: Mohamed, Adham, et al.
Publicado: (2020)

213. Assessment of Compliance with Order Set and Bundle for Management of Staphylococcus aureus Bacteremia
por: Flynn, Ryan R, et al.
Publicado: (2021)

1817. Characteristics and Outcomes in Patients with Staphylococcus lugdunensis Bacteremia Compared with Staphylococcus aureus and Staphylococcus epidermidis Bacteremia
por: Yukawa, Satomi, et al.
Publicado: (2022)

67. Impact of a Pharmacist-Driven Collaborative Initiative on Staphylococcus aureus Bacteremia Management
por: Kufel, Wesley D, et al.
Publicado: (2020)

311. The Role of Transthoracic Echocardiography in Staphylococcus aureus Bacteremia; A Retrospective Chart Review
por: Aldred, Bruce M, et al.
Publicado: (2020)

227. Staphylococcus aureus bacteremia: back to normal
por: Pedromingo Kus, Miguel Sebastian, et al.
Publicado: (2023)

292. Impact of the BACT/ALERT VIRTUO blood culture system in the management of Staphylococcus aureus bacteremia
por: Chavez, Miguel A, et al.
Publicado: (2020)

307. Rapid Resistance Development to Three Antistaphylococcal Therapies in Daptomycin-tolerant Staphylococcus aureus Bacteremia
por: Miller, Christopher R, et al.
Publicado: (2020)

301. Penicillin Versus Cefazolin or Anti-staphylococcal Penicillins for Penicillin-Susceptible Staphylococcus aureus Bacteremia
por: Aldhaeefi, Mohammed, et al.
Publicado: (2020)

302. Peripheral IV catheters, a common source of healthcare-associated Staphylococcus aureus bacteremia
por: Young, Heather, et al.
Publicado: (2020)

264. Anti-platelet Therapy Significantly Reduces Inpatient Mortality in Patients with Staphylococcus aureus Bacteremia
por: Caffrey, Aisling, et al.
Publicado: (2020)

190. Outcomes of Early Ceftaroline-based Combination Therapy for Methicillin-resistant Staphylococcus aureus Bacteremia
por: Dolan, Mackenzie, et al.
Publicado: (2021)

187. Vancomycin Plus Ceftaroline Salvage Therapy for Persistent Methicillin-Resistant Staphylococcus aureus Bacteremia
por: Kufel, Wesley D, et al.
Publicado: (2021)

216. Bacterial Genotype and Clinical Outcomes in Solid Organ Transplant Recipients with Staphylococcus aureus Bacteremia
por: Eichenberger, Emily, et al.
Publicado: (2021)

2099. Catheter-related Staphylococcus aureus Bacteremia and Septic Thrombosis: The Role of Anticoagulation and Duration of Intravenous Antibiotic Therapy
por: Dib, Rita Wilson, et al.
Publicado: (2018)

282. Epidemiological Evaluation of Methicillin-Resistant Staphylococcus aureus (MRSA) and Methicillin-Susceptible Staphylococcus aureus (MSSA) Bacteremia: A Comprehensive Cancer Center’s 10-Year Experience
por: Ford, Charles R, et al.
Publicado: (2020)

Staphylococcus aureus Bacteremia in Children: The Effect of Methicillin Resistance
por: Hamdy, Rana F, et al.
Publicado: (2017)

1060. Risk Factors for Recurrent Staphylococcus aureus Bacteremia
por: Choi, Seong-Ho, et al.
Publicado: (2018)

97. The Utilization of Echocardiography in Children with Staphylococcus aureus Bacteremia
por: Bui, Richard, et al.
Publicado: (2023)

276. Comparison of Ceftaroline in Combination with Either Vancomycin or Daptomycin for the Treatment of Methicillin-resistant Staphylococcus aureus Bacteremia
por: Welch, Stephanie N, et al.
Publicado: (2020)

280. Description of Transesophageal Echocardiography Prescribing Practices in non-Staphylococcus aureus Bacteremia with Application of Scoring Systems
por: Luttmann, Kelly F, et al.
Publicado: (2020)

1373. Racial Disparities in Clinical Characteristics and Outcomes for Methicillin Susceptible and Methicillin-Resistant Staphylococcus aureus Bacteremia
por: Mohnasky, Michael C, et al.
Publicado: (2021)

2255. The Use of Dalbavancin for Staphylococcus aureus Bacteremia in Persons Who Inject Drugs (PWID)
por: Van Hise, Nicholas W, et al.
Publicado: (2019)

Prevention of nosocomial bacteremia associated with Staphylococcus aureus in Benin
por: Ahoyo, TA, et al.
Publicado: (2015)

312. Unplanned Readmission after Hospitalization with Staphylococcus aureus Bacteremia in Children: a Multistate Population Based Study
por: Inagaki, Kengo, et al.
Publicado: (2020)

275. Comparison of Cefazolin versus Nafcillin for Methicillin-Susceptible Staphylococcus aureus Bacteremia with a Deep-Seated Source
por: Mersinger, Katherine E, et al.
Publicado: (2020)

335. Staphylococcus aureus Bacteremia as a Potential and Severe Complication from Intramuscular COVID-19 Vaccine Injection
por: Kus, Miguel Sebastian Pedromingo
Publicado: (2021)

181. Demographic and Geographic Epidemiology of Staphylococcus aureus Bacteremia using Geographic Information Systems Mapping and Spatial Statistics
por: Marshall, Julia, et al.
Publicado: (2021)

Impact of an Antimicrobial Stewardship Initiative Focused on Staphylococcus aureus Bacteremia
por: Gregory, Eric, et al.
Publicado: (2017)

1065. Evaluation of a Staphylococcus aureus Bacteremia Treatment Checklist
por: Soukup, Hailey, et al.
Publicado: (2018)

672 Staphylococcus aureus Bacteremia in Hospitalized Children
por: Klieger, Sarah B., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_gqp0c9o5mhpagg2t7g6ick7uh0